10-Q/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

____________________

FORM 10-Q / A

(Amendment No. 1)

____________________

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended June 30, 2012
OR
o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from_________ to __________

Commission File Number 001-14498

____________________________________

BLUEFLY, INC.

(Exact name of registrant as specified in its charter)

____________________________________

Delaware	13-3612110
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification Number)
42 West 39th Street, New York, NY (Address of principal executive offices)	10018 (Zip Code)

Registrant’s telephone number, including area code: (212) 944-8000

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer o	Accelerated filer o	Non-accelerated filer o	Smaller reporting company x
		(Do not check if a smaller reporting company)

Indicate by check mark if the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

As of August 13, 2012, there were 28,576,612 shares of Common Stock, $.01 par value, of the registrant outstanding.

EXPLANATORY NOTE

The purpose of this Amendment No. 1 to Bluefly, Inc.’s (the “Company”) quarterly report on Form 10-Q for the quarterly period ended June 30, 2012, as originally filed with the Securities and Exchange Commission on August 14, 2012 (the “Original Form 10-Q”), is being filed solely to furnish Exhibit 101 to the Form 10-Q in accordance with Rule 405 of Regulation S-T.

Pursuant to Rule 405(a)(2)(ii) of Regulation S-T, this Exhibit 101 is permitted to be furnished by amendment within 30 days of the original filing date of the Original Form 10-Q.

Exhibit 101 consists of the following materials from the Company’s Original Form 10-Q formatted in XBRL (eXtensible Business Reporting Language):

101.INS	XBRL	Instance Document
101.SCH	XBRL	Taxonomy Extension Schema
101.CAL	XBRL	Taxonomy Extension Calculation Linkbase
101.DEF	XBRL	Taxonomy Extension Definition Linkbase
101.LAB	XBRL	Taxonomy Extension Label Linkbase
101.PRE	XBRL	Taxonomy Extension Presentation Linkbase

This Amendment No. 1 does not reflect events occurring after August 14, 2012 and does not update or modify in any way the consolidated results of operations, financial position, cash flows or other disclosures in the Company’s Original Form 10-Q.

As required by Rule 12b-15 under the Securities and Exchange Act of 1934, as amended, new certifications by our principal executive officer and principal financial officer are filed as exhibits to this Amendment No. 1 to the Company’s Form 10-Q under Item 6 of Part II.

Pursuant to Rule 406T of Regulation S-T, the interactive files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, and Section 18 of the Securities Exchange Act of 1934, as amended.

Part II - OTHER INFORMATION

Item 6. Exhibits

The following is a list of exhibits filed as part of this Report:

Exhibit Number	Description
10.1*	Note and Warrant Purchase Agreement, dated August 13, 2012, by and among the Company, Prentice Consumer Partners, LP and Rho Ventures VI, L.P.
10.2*	Secured Subordinated Promissory Note, dated August 13, 2012, by and between the Company and Prentice Consumer Partners, LP.
10.3*	Secured Subordinated Convertible Promissory Note, dated August 13, 2012, by and between the Company and Rho Ventures VI, L.P.
10.4*	Warrant No. 1, dated August 13, 2012, issued to Prentice Consumer Partners LP.
10.5*	Warrant No. 2, dated August 13, 2012, issued to Rho Ventures VI, L.P.
10.6*	First Amendment to Amended and Restated Credit Agreement, dated April 18, 2012, by and between the Company and Wells Fargo.
10.7*	Employment Agreement, dated June 12, 2012, by and between the Company and Scott Erdman.
31.1**	Certification Pursuant to Rule 13a-14(a)/15d-14(a).
31.2**	Certification Pursuant to Rule 13a-14(a)/15d-14(a).
32.1**	Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**	Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS**	XBRL Instance Document.
101.SCH**	XBRL Taxonomy Extension Schema.
101.CAL**	XBRL Taxonomy Extension Calculation Linkbase.
101.DEF**	XBRL Taxonomy Extension Definition Linkbase.
101.LAB**	XBRL Taxonomy Extension Label Linkbase.
101.PRE**	XBRL Taxonomy Extension Presentation Linkbase.

* Filed previously

** Filed with this Amendment No. 1 to the quarterly report on Form 10-Q

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

BLUEFLY, INC.

By: /s/ Joseph C. Park

Joseph C. Park

Chief Executive Officer

By: /s/ Kara B. Jenny

Kara B. Jenny

Chief Financial Officer

September 7, 2012

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A)

I, Joseph C. Park, certify that:

1. I have reviewed this amendment no. 1 to the quarterly report on Form 10-Q for the quarter ended June 30, 2012 of Bluefly, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the consolidated financial condition, results of operations and cash flows of the registrant as of, and for the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and we have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiary, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting;

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  September 7, 2012	/s/ Joseph C. Park
	Joseph C. Park
	Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A)

I, Kara B. Jenny, certify that:

1. I have reviewed this amendment no. 1 to the quarterly report on Form 10-Q for the quarter ended June 30, 2012 of Bluefly, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the consolidated financial condition, results of operations and cash flows of the registrant as of, and for the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and we have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiary, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting;

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  September 7, 2012	/s/ Kara B. Jenny
	Kara B. Jenny
	Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with Amendment No. 1 to the Quarterly Report of Bluefly, Inc. (the “Company”) on Form 10-Q for the three and six months ended June 30, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Joseph C. Park, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company.

/s/ Joseph C. Park

Joseph C. Park

Chief Executive Officer

September 7, 2012

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with Amendment No.1 to the Quarterly Report of Bluefly, Inc. (the “Company”) on Form 10-Q for the three and six months ended June 30, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kara B. Jenny, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company.

/s/ Kara B. Jenny

Kara B. Jenny

Chief Financial Officer

September 7, 2012

XML

Note 5 - Acquisition (Detail) - Estimated Amortization Expense For Unamortized Acquired Intangible Assets (USD $)	Jun. 30, 2012
2012	$ 120,000
2013	122,000
2014	87,000
2015	86,000
2016	85,000
2017	3,000
	$ 503,000

XML

Note 3 - Fair Value

6 Months Ended

Jun. 30, 2012

Fair Value Disclosures [Text Block]

NOTE 3 – FAIR VALUE

The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, other assets, accounts payable and accrued expenses. The carrying amounts of these financial instruments approximate fair value due to their short maturities.

XML

Note 8 - Subsequent Event (Detail) (USD $)	1 Months Ended
	Aug. 31, 2012	Aug. 13, 2012
Term of "Notes"	1 year
Term of Warrants Issued in Connection With Notes Issuance	7 years
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)		1.05
Debt Instrument, Covenant Description	The terms of the Notes contain a financial covenant in which the Company is to maintain current assets in excess of $20,000,000 including cash and cash equivalents, accounts receivable, net and inventories, net (the "Financial Covenant"). In the event that the Company does not maintain this Financial Covenant, the outstanding principal and accrued interest expense of the Notes shall be accelerated and automatically become due and payable.
Convertible Notes Payable [Member] | Rho Ventures VI, L.P. [Member]
Debt Instrument, Face Amount (in Dollars)		$ 1,500,000
Debt Instrument, Interest Rate, Stated Percentage		12.00%
Debt Instrument, Convertible, Terms of Conversion Feature	The Rho Notes are convertible, at the holder's option, (a) into equity securities that the Company might issue in any subsequent round of financing that results in proceeds to the Company of at least $7,500,000 (a "Qualified Financing") at a price equal to the lowest price per share paid by any investor in such Qualified Financing or (b) into shares of the Company's common stock at a price per share equal to $1.05, which represents the fair market value on the Closing Date.
Debt Instrument, Convertible, Conversion Price (in Dollars per share)		$ 1.05
Loans Payable [Member] | Prentice Consumer Partners, LP [Member]
Debt Instrument, Face Amount (in Dollars)		$ 1,500,000
Debt Instrument, Interest Rate, Stated Percentage		15.00%
Loan Processing Fee, Percentage		2.00%
Rho Ventures VI, L.P. [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)		476,190
Prentice Consumer Partners, LP [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)		476,190

XML

Note 7 - Net Loss Per Share Attributable To Bluefly, Inc. Stockholders (Detail) - Basic and Diluted Weighted Average Common Shares Outstanding (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Net loss attributable to Bluefly, Inc. stockholders (in Dollars)	$ (4,949,000)	$ (1,032,000)	$ (12,819,000)	$ (2,310,000)
Weighted average common shares outstanding (basic)	28,576,612	24,611,736	28,549,924	24,608,486
Stock option awards and warrants(1)(2)
Restricted stock awards(1)
Weighted average common shares outstanding (diluted)	28,576,612	24,611,736	28,549,924	24,608,486
Stock option awards and warrants		330,861	1,821	419,294

XML

Note 2 - Basis of Presentation

6 Months Ended

Jun. 30, 2012

Business Description and Basis of Presentation [Text Block]

NOTE 2 – BASIS OF PRESENTATION

The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnote disclosures required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting mainly of normal recurring accruals) considered necessary for a fair presentation have been included. The consolidated results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year due to seasonal and other factors. For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company's Form 10-K for the year ended December 31, 2011.

The Company has sustained cumulative net losses and negative cash flows from operations since inception. As of June 30, 2012, the Company had an accumulated deficit of $175,304,000. The Company’s ability to meet its obligations in the ordinary course of business is dependent on its ability to establish profitable operations, or find sources to fund operations. The Company believes that its existing cash balance, proceeds from the recent bridge financing further discussed in Note 8 – Subsequent Events, combined with working capital and the funds available from the Company’s existing credit facility, will be sufficient to enable the Company to meet planned expenditures through at least the next 12 months.

Should the Company experience unforeseen increases in expenditures or should estimated revenues not materialize, these conditions could significantly impair its ability to fund future operations. Should the Company experience unanticipated losses or expenditures that exceed current estimates, management would implement a cost reduction plan, that includes a reduction in work force as well as reductions in overhead costs and capital expenditures, and/or attempt to raise additional debt or equity financing. There can be no assurance that the Company will achieve or sustain positive cash flows from operations or profitability. If the Company is unable to maintain adequate liquidity, future operations will need to be scaled back or discontinued.

Summary of significant accounting policies

Sales incentives

The Company frequently offers sales incentives to customers to receive a reduction in the sales price of merchandise. Sales incentives include discounts, coupons, daily deal programs and through our online marketing programs. For sales incentives issued to customers in conjunction with the sale of merchandise, the Company recognizes the reduction in gross sales at the time of sale.

Intangible assets

Intangible assets are recorded at cost, net of accumulated amortization and are amortized on a straight-line basis over their estimated useful lives. No significant residual value is estimated for the intangible assets.

The Company evaluates the recoverability of intangible assets at least annually for possible impairment or whenever events or circumstances indicate that the carrying value of such assets may not be recoverable.

Concentration

For the three months ended June 30, 2012 and 2011, the Company, excluding Eyefly, acquired approximately 53% and 49%, respectively, of its inventory from its two largest suppliers.

For the six months ended June 30, 2012 and 2011, the Company, excluding Eyefly, acquired approximately 58% and 50%, respectively, of its inventory from its three largest suppliers.

Related-party transactions

For the three months ended June 30, 2012 and 2011, Eyefly did not purchase any inventory from A + D Labs.

For the six months ended June 30, 2012 and 2011, Eyefly purchased $98,000 and $170,000, respectively from A + D Labs pursuant to a management services agreement.

As of June 30, 2012 and December 31, 2011, Eyefly had related party amounts of $222,000 and $105,000 due to A + D Labs, respectively, which is presented as part of Accounts payable within the Consolidated Balance Sheets.

As of June 30, 2012 and December 31, 2011, Eyefly had related party amounts of $245,000 and $227,000 due to the Company, respectively, which are eliminated in consolidation.

Recently issued, but not yet effective, accounting pronouncements

The Company is not aware of any recently issued, but not yet effective, accounting pronouncements that would have a significant impact on the Company’s consolidated financial position or results of operations.

XML

Consolidated Balance Sheets (June 30, 2012 Unaudited) (USD $)	Jun. 30, 2012	Dec. 31, 2011
Current assets:
Cash and cash equivalents	$ 1,686,000	$ 4,413,000
Accounts receivable — net of allowance for doubtful accounts	1,633,000	2,597,000
Inventories, net	25,243,000	32,083,000
Prepaid inventory	1,350,000	2,690,000
Prepaid expenses	71,000	247,000
Other current assets	394,000	706,000
Total current assets	30,377,000	42,736,000
Property and equipment, net	6,512,000	5,705,000
Intangible assets, net	503,000
Other assets	200,000	185,000
Total assets	37,592,000	48,626,000
Current liabilities:
Accounts payable	12,661,000	10,192,000
Allowance for sales returns	2,482,000	3,124,000
Accrued expenses and other current liabilities	3,186,000	4,446,000
Deferred revenue	3,472,000	4,235,000
Total current liabilities	21,801,000	21,997,000
Deferred rent liability	397,000	373,000
Total liabilities	22,198,000	22,370,000
Bluefly, Inc. stockholders’ equity:
Common stock – $.01 par value; 50,000,000 shares authorized as of June 30, 2012 and December 31, 2011, respectively; 28,915,010 and 28,629,296 shares issued as of June 30, 2012 and December 31, 2011, respectively, 28,576,612 and 28,290,898 shares outstanding as of June 30, 2012 and December 31, 2011, respectively	286,000	283,000
Treasury stock	(1,824,000)	(1,824,000)
Additional paid-in capital	192,355,000	190,296,000
Accumulated deficit	(175,304,000)	(162,485,000)
Total Bluefly, Inc. stockholders’ equity	15,513,000	26,270,000
Non-controlling interest in Eyefly LLC	(119,000)	(14,000)
Total stockholders’ equity	15,394,000	26,256,000
Total liabilities and stockholders’ equity	$ 37,592,000	$ 48,626,000

XML

Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Cash flows from operating activities:
Net loss	$ (12,924,000)	$ (2,546,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expenses	1,428,000	1,401,000
Stock-based compensation expenses	1,262,000	435,000
Provisions for returns	(326,000)	(207,000)
Bad debt expense	196,000	195,000
Reserve for inventory obsolescence	(562,000)	133,000
Amortization expense related to warrants issued to third-party	200,000
Deferred rent expense	24,000	34,000
(Increase) decrease in:
Accounts receivable	758,000	(346,000)
Inventories	7,402,000	(5,609,000)
Prepaid inventory	1,340,000	(1,846,000)
Prepaid expenses	176,000	(33,000)
Other assets	283,000	104,000
Increase (decrease) in:
Accounts payable	2,469,000	3,889,000
Accrued expenses and other current liabilities	(1,576,000)	(596,000)
Deferred revenue	(763,000)	(745,000)
Net cash used in operating activities	(613,000)	(5,737,000)
Cash flows from investing activities:
Purchases of property and equipment	(2,114,000)	(1,517,000)
Net cash used in investing activities	(2,114,000)	(1,517,000)
Cash flows from financing activities:
Proceeds from capital contribution for the purchase of non-controlling interest in subsidiary by third-party		336,000
Proceeds from exercise of stock options		18,000
Net cash provided by financing activities		354,000
Net decrease in cash and cash equivalents	(2,727,000)	(6,900,000)
Cash and cash equivalents – beginning of period	4,413,000	10,429,000
Cash and cash equivalents – end of period	1,686,000	3,529,000
Supplemental disclosure of cash flow information:
Cash paid for interest expense	86,000	144,000
Supplemental disclosure of non-cash financing disclosure of cash flow information:
Issuance of common stock for asset acquisition	$ 600,000

XML

Note 5 - Acquisition (Detail) (USD $)	1 Months Ended	3 Months Ended	6 Months Ended
	Jan. 31, 2012	Jun. 30, 2012	Jun. 30, 2012	Jan. 10, 2012
Business Acquisition, Cost of Acquired Entity, Purchase Price				$ 611,000
Business Acquisition, Cost of Acquired Entity, Transaction Costs				11,000
Stock Issued During Period, Shares, Acquisitions (in Shares)	285,714
Equity Issuance, Per Share Amount (in Dollars per share)	$ 2.10
Amortization of Acquired Intangible Assets		$ 59,000	$ 108,000

XML

Note 5 - Acquisition (Detail) - Carrying Value of Acquired Intangible Assets (USD $)	6 Months Ended
	Jun. 30, 2012
Gross Carrying Amount	$ 611,000
Accumulated Amortization	(108,000)
Net Carrying Value	503,000
Contractual Rights [Member]
Weighted Average Useful Life (Years)	5 years
Gross Carrying Amount	428,000
Accumulated Amortization	(39,000)
Net Carrying Value	389,000
Developed Technology Rights [Member]
Weighted Average Useful Life (Years)	1 year
Gross Carrying Amount	111,000
Accumulated Amortization	(51,000)
Net Carrying Value	60,000
Customer Contracts [Member]
Weighted Average Useful Life (Years)	2 years
Gross Carrying Amount	62,000
Accumulated Amortization	(14,000)
Net Carrying Value	48,000
Trade Names [Member]
Weighted Average Useful Life (Years)	1 year
Gross Carrying Amount	10,000
Accumulated Amortization	(4,000)
Net Carrying Value	$ 6,000

XML

Note 1 - The Company

6 Months Ended

Jun. 30, 2012

Nature of Operations [Text Block]

NOTE 1 – THE COMPANY

Bluefly, Inc. (the “Company”) is a leading Internet retailer that sells over 350 brands of designer apparel and accessories at discounts of up to 75% off of retail value. The Company’s e-commerce web site, bluefly.com (“Bluefly.com” or “Web Site”), was launched in September 1998. In December 2011, the Company expanded its portfolio of web sites by launching its belleandclive.com web site (“Belle & Clive”), a members-only shopping destination that presents highly-curated selections of important brands via limited-time sale events.

In 2011, the Company and A + D Labs LLC (“A + D Labs” and, collectively with the Company, the “Members”) entered into a Limited Liability Company Operating Agreement (the “Operating Agreement”) in connection with the formation of Eyefly LLC (“Eyefly”), a Delaware limited liability company, which is currently owned 52% by the Company and 48% by A + D Labs. Eyefly was formed for the purposes of developing and operating an e-commerce web site and related online and mobile applications focused on selling fashionable prescription eyewear directly to consumers. Eyefly launched its e-commerce web site, eyefly.com (“Eyefly.com” and together with Bluefly.com and Belle & Clive, the “Web Sites”), in June 2011.

Pursuant to the Operating Agreement, the Members made an aggregate of $700,000 of initial capital contributions in cash ($364,000 from the Company and $336,000 from A + D Labs) and agreed to make an additional $600,000 of capital contributions ($312,000 from the Company and $288,000 from A + D Labs) as necessary. In October 2011, the Members made additional capital contributions in the aggregate of $200,000 in cash ($104,000 from the Company and $96,000 from A + D Labs) pursuant to the Operating Agreement. The Operating Agreement provides the Company with an option (the “Call Option”) to purchase A + D Labs’ equity in Eyefly on or after the four year anniversary of formation at a valuation based on a specified multiple of adjusted EBITDA. In the event the Company exercises the Call Option, A + D Labs has the option to receive the purchase price for equity in cash or in shares of the Company’s Common Stock, provided that the total number of shares issued to A + D Labs pursuant to such option cannot exceed 4,918,856 shares (which is less than 20% of the outstanding shares of the Company’s Common Stock as of the date of the Operating Agreement).

As of June 30, 2012, the total assets of Eyefly represent 1.3% of the total consolidated assets of the Company. For the three and six months ended June 30, 2012, the total net sales of Eyefly each represent less than 1% of the total consolidated net sales of the Company.

On January 3, 2012, the Company formed a new wholly-owned subsidiary EVT Acquisition LLC, a New York limited liability company (“EVT”), in connection with the Company’s acquisition of assets discussed further in Note 5 – Acquisition.

XML

Consolidated Balance Sheets (June 30, 2012 Unaudited) (Parentheticals) (USD $)	Jun. 30, 2012	Dec. 31, 2011
Common stock par value, per share (in Dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	50,000,000	50,000,000
Common Stock, shares issued	28,915,010	28,629,296
Common stock, shares outstanding	28,576,612	28,290,898

XML

Note 6 - Stock-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2012

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

	Number of Shares			Weighted Average Exercise Price Per Share
Balance at December 31, 2011		2,795,182		$	2.84
Options granted		1,146,513		$	1.73
Options cancelled		(103,902	)	$	2.12
Options expired		(950	)	$	14.13
Options exercised		--		$	--
Balance at June 30, 2012		3,836,843		$	2.53
Vested at December 31, 2011		901,341		$	3.76
Vested at June 30, 2012		1,612,987		$	3.14

XML

Document And Entity Information	6 Months Ended
	Jun. 30, 2012	Aug. 13, 2012
Document and Entity Information [Abstract]
Entity Registrant Name	Bluefly Inc
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		28,576,612
Amendment Flag	false
Entity Central Index Key	0001030896
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Jun. 30, 2012
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q2

XML

Note 7 - Net Loss Per Share Attributable To Bluefly, Inc. Stockholders (Tables)

6 Months Ended

Jun. 30, 2012

Schedule of Weighted Average Number of Shares [Table Text Block]

	Three Months Ended June 30,
	2012			2011
Net loss attributable to Bluefly, Inc. stockholders	$	(4,949,000	)	$	(1,032,000	)
Weighted average common shares outstanding (basic)		28,576,612			24,611,736
Stock option awards and warrants(1)(2)		--			--
Restricted stock awards(1)		--			--
Weighted average common shares outstanding (diluted)		28,576,612			24,611,736

Stock option awards and warrants -- 330,861

	Six Months Ended June 30,
	2012			2011
Net loss attributable to Bluefly, Inc. stockholders	$	(12,819,000	)	$	(2,310,000	)
Weighted average common shares outstanding (basic)		28,549,924			24,608,486
Stock option awards and warrants(1)(2)		--			--
Restricted stock awards(1)		--			--
Weighted average common shares outstanding (diluted)		28,549,924			24,608,486

Stock option awards and warrants 1,821 419,294

XML

Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Net sales	$ 22,215,000	$ 24,037,000	$ 46,481,000	$ 45,730,000
Cost of sales	17,786,000	16,544,000	38,307,000	30,042,000
Gross profit	4,429,000	7,493,000	8,174,000	15,688,000
Selling and fulfillment expenses	5,150,000	4,609,000	10,608,000	8,946,000
Marketing expenses	2,231,000	2,098,000	4,809,000	5,098,000
General and administrative expenses	1,955,000	1,927,000	5,496,000	4,039,000
Total operating expenses	9,336,000	8,634,000	20,913,000	18,083,000
Operating loss	(4,907,000)	(1,141,000)	(12,739,000)	(2,395,000)
Other interest expense, net	(113,000)	(55,000)	(185,000)	(151,000)
Net loss	(5,020,000)	(1,196,000)	(12,924,000)	(2,546,000)
Less: net loss attributable to non-controlling interest in Eyefly LLC	(71,000)	(164,000)	(105,000)	(236,000)
Net loss attributable to Bluefly, Inc. stockholders	$ (4,949,000)	$ (1,032,000)	$ (12,819,000)	$ (2,310,000)
Basic and diluted net loss per common share attributable to Bluefly, Inc. stockholders (in Dollars per share)	$ (0.17)	$ (0.04)	$ (0.45)	$ (0.09)
Weighted average common shares outstanding (basic and diluted) (in Shares)	28,576,612	24,611,736	28,549,924	24,608,486

XML

Note 6 - Stock-Based Compensation

6 Months Ended

Jun. 30, 2012

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

NOTE 6 – STOCK-BASED COMPENSATION

Authoritative guidance relating to stock-based compensation requires the Company to measure compensation cost for stock awards at fair value and recognize compensation over the service period for awards expected to vest. Total stock-based compensation expense recorded in the Consolidated Statements of Operations was $287,000 and $224,000 for the three months ended June 30, 2012 and 2011, respectively, and $1,262,000 and $435,000 for the six months ended June 30, 2012 and 2011, respectively.

Stock Option Awards

The fair value of stock option awards granted is estimated on the date of grant using a Black-Scholes option pricing model. Expected volatilities are calculated based on the historical volatility of the price of the Company's Common Stock. Management monitors stock option exercise and employee termination patterns to estimate forfeiture rates within the valuation model. The expected holding period of stock options represents the period of time that stock options granted are expected to be outstanding. The risk-free interest rate for periods within the expected life of the stock option award is based on the interest rate of U.S. Treasury notes in effect on the date of the grant.

The following table summarizes the Company’s stock option activity:

	Number of Shares			Weighted Average Exercise Price Per Share
Balance at December 31, 2011		2,795,182		$	2.84
Options granted		1,146,513		$	1.73
Options cancelled		(103,902	)	$	2.12
Options expired		(950	)	$	14.13
Options exercised		--		$	--
Balance at June 30, 2012		3,836,843		$	2.53
Vested at December 31, 2011		901,341		$	3.76
Vested at June 30, 2012		1,612,987		$	3.14

During the second quarter of 2012, 86,402 stock option awards were cancelled through normal employee attrition, of which 1,502 stock option awards were vested and 84,900 stock option awards were non-vested. During the second quarter of 2012, 182,232 stock option awards vested. The total fair value of the stock options that vested during the second quarter of 2012 was approximately $309,000. There were 545,013 stock option awards granted during the second quarter of 2012. At June 30, 2012, there was no aggregate intrinsic value of the fully vested stock option awards and the weighted average remaining contractual life of the stock options was approximately seven years. The Company did not capitalize any compensation cost, or modify any of its stock option awards during the second quarter of 2012. There were no stock option exercises and no cash was used to settle equity instruments granted under the Company’s equity incentive plans during the second quarter of 2012.

As of June 30, 2012, the total compensation cost related to non-vested stock option awards not yet recognized was $3,081,000. Total compensation cost is expected to be recognized over three years on a weighted average basis.

For the three months ended June 30, 2012 and 2011, the Company recognized expense of approximately $287,000 and $224,000, respectively, and $1,262,000 and $432,000 for the six months ended June 30, 2012 and 2011, respectively, in connection with these awards.

Restricted Stock Awards

There were no restricted stock awards issued during the three and six months ended June 30, 2012 or outstanding as of June 30, 2012 and, accordingly, the Company did not recognize any expense related to restricted stock awards. There were no restricted stock awards issued during the three months ended June 30, 2011. For the six months ended June 30, 2011, the Company recognized approximately $3,000 in expense related to restricted stock awards.

XML

Note 5 - Acquisition

6 Months Ended

Jun. 30, 2012

Business Combination Disclosure [Text Block]

NOTE 5 – ACQUISITION

On January 10, 2012, the Company, through a newly-formed wholly-owned subsidiary, EVT, entered into an asset purchase agreement with Moda for Friends LLC (the “Seller”) and purchased certain intangible assets that include a contractual-related agreement, purchased customer list, developed technologies and trademarks (the “Acquired Intangible Assets”) owned by the Seller for a total purchase price of $611,000 (includes transaction costs of $11,000), which the Company paid through the issuance of 285,714 shares of its Common Stock, with each share being valued at $2.10 (the closing price of the Common Stock on the day prior to the consummation of the transaction). The Company completed the asset acquisition because it would facilitate the launch and operation of its own flash sales business.

The Company has allocated the purchase price of the acquisition among the assets, based on their relative fair values, as follows:

Contract-related intangible	$	428,000
Developed technology-related intangible		111,000
Customer-related intangible		62,000
Tradename		10,000
Total purchase price	$	611,000

The carrying values of the Acquired Intangible Assets at June 30, 2012 were as follows:

	Weighted Average Useful Life (Years)	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Contract-related intangible	5	$	428,000	$	(39,000	)	$	389,000
Developed technology-related intangible	1		111,000		(51,000	)		60,000
Customer-related intangible	2		62,000		(14,000	)		48,000
Tradename	1		10,000		(4,000	)		6,000
		$	611,000	$	(108,000	)	$	503,000

For the three and six months ended June 30, 2012, the Company recorded $59,000 and $108,000, respectively, in amortization expenses in the Consolidated Statements of Operations related to the Acquired Intangible Assets.

The estimated amortization expense for the unamortized Acquired Intangible Assets for the next five years and thereafter is as follows:

2012	$	120,000
2013		122,000
2014		87,000
2015		86,000
2016		85,000
2017		3,000
	$	503,000

XML

Note 5 - Acquisition (Detail) - Purchase Price Allocation (USD $)	Jan. 10, 2012
Total purchase price	$ 611,000
Contractual Rights [Member]
Purchase Price/Fair Value of Assets	428,000
Developed Technology Rights [Member]
Purchase Price/Fair Value of Assets	111,000
Customer Contracts [Member]
Purchase Price/Fair Value of Assets	62,000
Trade Names [Member]
Purchase Price/Fair Value of Assets	$ 10,000

XML

Note 1 - The Company (Detail) (USD $)	1 Months Ended	12 Months Ended
	Oct. 31, 2011	Dec. 31, 2011	Jun. 30, 2012
Partners' Capital Account, Contributions	$ 200,000	$ 700,000
Partners' Capital Account, Additional Capital Contributions Agreed Upon If Necessary		600,000
Assets of subsidiary as percentage of parent's consolidated assets			1.30%
Net sales of subsidiary as percentage of total consolidated net sales of parent			1.00%
Initial Ownership Percentage - Company [Member]
Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest		52.00%
Initial Ownership Percentage - A+D Labs [Member]
Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest		48.00%
Initial Contribution from the Company [Member]
Limited Partners' Contributed Capital	104,000	364,000
Partners' Capital Account, Additional Capital Contributions Agreed Upon If Necessary		312,000
Contribution from A+D Labs [Member]
Limited Partners' Contributed Capital	96,000	336,000
Partners' Capital Account, Additional Capital Contributions Agreed Upon If Necessary		$ 288,000

XML

Note 4 - Commitments and Contingencies (Tables)

6 Months Ended

Jun. 30, 2012

Contractual Obligation, Fiscal Year Maturity Schedule [Table Text Block]

2012	$	982,000
2013		762,000
2014		488,000
2015		150,000
	$	2,382,000

XML

Note 7 - Net Loss Per Share Attributable To Bluefly, Inc. Stockholders

6 Months Ended

Jun. 30, 2012

Earnings Per Share [Text Block]

NOTE 7 – NET LOSS PER SHARE ATTRIBUTABLE TO BLUEFLY, INC. STOCKHOLDERS

Basic net loss per common share attributable to Bluefly, Inc. stockholders excludes dilution and is computed by dividing net loss attributable to Bluefly, Inc. stockholders by the weighted average number of common shares outstanding for the period.

Diluted net loss per common share attributable to Bluefly, Inc. stockholders is computed by dividing net loss attributable to Bluefly, Inc. stockholders by the weighted average number of common shares outstanding for the period, adjusted to reflect potentially dilutive securities using the treasury stock method for stock option awards, warrants, restricted stock awards and deferred stock unit awards. Due to the Company’s net loss, (i) stock option awards and warrants to purchase shares of Common Stock and (ii) restricted stock awards that have not yet vested were not included in the computation of diluted loss per common share attributable to Bluefly, Inc. stockholders, as the effects would be anti-dilutive. Accordingly, basic and diluted weighted average shares outstanding are equal for the following periods presented:

	Three Months Ended June 30,
	2012			2011
Net loss attributable to Bluefly, Inc. stockholders	$	(4,949,000	)	$	(1,032,000	)
Weighted average common shares outstanding (basic)		28,576,612			24,611,736
Stock option awards and warrants(1)(2)		--			--
Restricted stock awards(1)		--			--
Weighted average common shares outstanding (diluted)		28,576,612			24,611,736

(1) For the three months ended June 30, 2012 and 2011, the Company had weighted average shares of the following potentially dilutive securities that were excluded:

Stock option awards and warrants -- 330,861

(2) Under the treasury-stock method, the Company excluded all stock option awards and warrants from the computation of weighted average shares outstanding as a result of the exercise price of the stock option awards and warrants being greater than the average market price of the Company’s Common Stock.

	Six Months Ended June 30,
	2012			2011
Net loss attributable to Bluefly, Inc. stockholders	$	(12,819,000	)	$	(2,310,000	)
Weighted average common shares outstanding (basic)		28,549,924			24,608,486
Stock option awards and warrants(1)(2)		--			--
Restricted stock awards(1)		--			--
Weighted average common shares outstanding (diluted)		28,549,924			24,608,486

(1) For the six months ended June 30, 2012 and 2011, the Company had weighted average shares of the following potentially dilutive securities that were excluded:

Stock option awards and warrants 1,821 419,294

(2) Under the treasury-stock method, the Company excluded all stock option awards and warrants from the computation of weighted average shares outstanding as a result of the exercise price of the stock option awards and warrants being greater than the average market price of the Company’s Common Stock.

XML

Note 8 - Subsequent Event

6 Months Ended

Jun. 30, 2012

Subsequent Events [Text Block]

NOTE 8 – SUBSEQUENT EVENT

On August 13, 2012 (the “Closing Date”), the Company entered into a Note and Warrant Purchase Agreement (the “Purchase Agreement”) with Rho Ventures VI, L.P. (“Rho”) and Prentice Consumer Partners, LP (“Prentice”, and together with Rho, the “Purchasers”) pursuant to which the Company issued (i) $1,500,000 aggregate principal amount of collateralized subordinated convertible promissory notes to Rho (the “Rho Notes”) and (ii) $1,500,000 aggregate principal amount of collateralized subordinated promissory notes to Prentice (the “Prentice Notes” and together with the Rho Notes, the “Notes”). 

The Rho Notes bear interest at 12% per annum, compounded annually, and interest is payable upon maturity or conversion.  The Prentice Notes bear interest at 15% per annum, compounded annually, and interest is payable quarterly.  Prentice received an origination fee on the Closing Date equal to 2 percent of its loan amount. The Rho Notes are convertible, at the holder's option, (a) into equity securities that the Company might issue in any subsequent round of financing that results in proceeds to the Company of at least $7,500,000 (a “Qualified Financing”) at a price equal to the lowest price per share paid by any investor in such Qualified Financing or (b) into shares of the Company’s common stock at a price per share equal to $1.05, which represents the fair market value on the Closing Date. 

The Notes have a one-year term but may become due prior to the end of such term in the event of a change of control or a Qualified Financing.  The Notes are collateralized by second priority liens on all assets of the Company.

In connection with the issuance of the Notes, the Company also issued warrants, having a term of seven years, to purchase 476,190 shares of the Company’s common stock (the “Warrants”) to each of Rho and Prentice at a price equal to $1.05 per share, which represents the fair market value of the Common Stock on the Closing Date.  Prior to stockholder approval, which the Company has agreed to seek promptly, the Rho Notes will be convertible and the Warrants will be exercisable only to the extent permitted by the applicable rules of the Nasdaq Capital Market. Rho and Prentice have sufficient voting power to approve this matter without the vote of any other stockholder.

The terms of the Notes contain a financial covenant in which the Company is to maintain current assets in excess of $20,000,000 including cash and cash equivalents, accounts receivable, net and inventories, net (the “Financial Covenant”). In the event that the Company does not maintain this Financial Covenant, the outstanding principal and accrued interest expense of the Notes shall be accelerated and automatically become due and payable.

XML

Note 5 - Acquisition (Tables)

6 Months Ended

Jun. 30, 2012

Schedule of Purchase Price Allocation [Table Text Block]

Contract-related intangible	$	428,000
Developed technology-related intangible		111,000
Customer-related intangible		62,000
Tradename		10,000
Total purchase price	$	611,000

Schedule of Finite-Lived Intangible Assets [Table Text Block]

	Weighted Average Useful Life (Years)	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Contract-related intangible	5	$	428,000	$	(39,000	)	$	389,000
Developed technology-related intangible	1		111,000		(51,000	)		60,000
Customer-related intangible	2		62,000		(14,000	)		48,000
Tradename	1		10,000		(4,000	)		6,000
		$	611,000	$	(108,000	)	$	503,000

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

2012	$	120,000
2013		122,000
2014		87,000
2015		86,000
2016		85,000
2017		3,000
	$	503,000

XML

Note 4 - Commitments and Contingencies (Detail) - Aggregate Cash Committment For All Future Base Salary Under Employment Contracts (USD $)	Jun. 30, 2012
2012	$ 982,000
2013	762,000
2014	488,000
2015	150,000
	$ 2,382,000

XML

Note 6 - Stock-Based Compensation (Detail) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Allocated Share-based Compensation Expense	$ 287,000	$ 224,000	$ 1,262,000	$ 435,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period (in Shares)	86,402		103,902
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period (in Shares)	182,232
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	309,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)	545,013		1,146,513
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	7 years
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Stock Options	3,081,000		3,081,000
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition			3 years
Stock Options [Member]
Allocated Share-based Compensation Expense	287,000	224,000	1,262,000	432,000
Restricted Stock [Member]
Allocated Share-based Compensation Expense				$ 3,000
Vested [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period (in Shares)	1,502
Non-Vested [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period (in Shares)	84,900

XML

Consolidated Statements of Changes in Stockholders Equity (Unaudited) (USD $)	Common Stock [Member]	Treasury Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]	Total
Balance at Dec. 31, 2011	$ 283,000	$ (1,824,000)	$ 190,296,000	$ (162,485,000)	$ (14,000)	$ 26,256,000
Balance (in Shares) at Dec. 31, 2011	28,290,898	338,398
Asset acquisition purchase	3,000		597,000			600,000
Asset acquisition purchase (in Shares)	285,714
Stock based compensation			1,262,000			1,262,000
Warrants issued to third-party			200,000			200,000
Net loss				(12,819,000)	(105,000)	(12,924,000)
Balance at Jun. 30, 2012	$ 286,000	$ (1,824,000)	$ 192,355,000	$ (175,304,000)	$ (119,000)	$ 15,394,000
Balance (in Shares) at Jun. 30, 2012	28,576,612	338,398

XML

Note 4 - Commitments and Contingencies

6 Months Ended

Jun. 30, 2012

Commitments and Contingencies Disclosure [Text Block]

NOTE 4 – COMMITMENTS AND CONTINGENCIES

Employment contracts

The Company has employment agreements with certain of its executive officers and other employees, which expire on various dates through June 30, 2015. On June 12, 2012, the Company entered into a new employment agreement with the Company’s Senior Vice President of Merchandising for a term continuing through June 30, 2015.

As of June 30, 2012, the Company's aggregate cash commitment for all future base salary under these employment contracts is as follows:

2012	$	982,000
2013		762,000
2014		488,000
2015		150,000
	$	2,382,000

XML

Note 6 - Stock-Based Compensation (Detail) - The following table summarizes the Company’s stock option activity: (USD $)	3 Months Ended	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2012
Outstanding Balance		2,795,182
Outstanding Balance (in Dollars per share)		$ 2.84
Vested Balance		901,341
Vested Balance (in Dollars per share)		$ 3.76
Options granted	545,013	1,146,513
Options granted (in Dollars per share)		$ 1.73
Options cancelled	(86,402)	(103,902)
Options cancelled (in Dollars per share)		$ 2.12
Options expired		(950)
Options expired (in Dollars per share)		$ 14.13
Options exercised
Options exercised (in Dollars per share)
Outstanding Balance	3,836,843	3,836,843
Outstanding Balance (in Dollars per share)	$ 2.53	$ 2.53
Vested Balance	1,612,987	1,612,987
Vested Balance (in Dollars per share)	$ 3.14	$ 3.14

XML

Note 2 - Basis of Presentation (Detail) (USD $)			6 Months Ended					3 Months Ended		6 Months Ended
	Jun. 30, 2012	Dec. 31, 2011	Jun. 30, 2012 A+D Labs [Member] Eyefly [Member]	Jun. 30, 2011 A+D Labs [Member] Eyefly [Member]	Dec. 31, 2011 A+D Labs [Member] Eyefly [Member]	Jun. 30, 2012 The Company [Member] Eliminated Upon Consolidation [Member] Eyefly [Member]	Dec. 31, 2011 The Company [Member] Eliminated Upon Consolidation [Member] Eyefly [Member]	Jun. 30, 2012 The Company, Excluding Eyefly [Member]	Jun. 30, 2011 The Company, Excluding Eyefly [Member]	Jun. 30, 2012 The Company, Excluding Eyefly [Member]	Jun. 30, 2011 The Company, Excluding Eyefly [Member]
Retained Earnings (Accumulated Deficit)	$ (175,304,000)	$ (162,485,000)
Percent of Inventory Acquired From Two Largest Suppliers								53.00%	49.00%
Percent of Inventory Acquired From Three Largest Suppliers										58.00%	50.00%
Related Party Transaction, Purchases from Related Party			98,000	170,000
Due to Related Parties			$ 222,000		$ 105,000	$ 245,000	$ 227,000